Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Athenahealth has been in the headlines in recent months due to the company’s efforts to champion interoperability through the CommonWell Health Alliance, reports of its customers’ high rate of successful Meaningful Use attestation and expansion into the ambulatory EHR market.
The Office of the National Coordinator for Health IT has submitted a report to Congress on information blocking, which prevents the sharing of patient information--a vital part of the national goal of seamless data sharing.
The number of hospitals sending electronic lab reports to public health agencies is increasing and is on track to meet future goals according to a progress update from the Centers for Disease Control and Prevention (CDC).
A new effort to drive cost transparency in healthcare comes in the form of a coalition of consumer advocacy organizations, drugmakers, insurers and providers that launched "Clear Choices."
The 90-day period to submit comments on the draft interoperability roadmap came to a close one week ago, and lots of stakeholders had lots to say about it.
KANSAS CITY, Mo., April 9, 2015 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, announced it will bring its patient app, HealtheLife(SM), to Apple Watch.
PLANO, Texas – April 8, 2015 – ZeOmega Inc., a market leader in population health solutions, today launched Jiva Integrated Medication Management, which gives providers and health plans the embedded intelligence and workflow needed to integrate medication management into the overall care management process.
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks.
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.
